Pharmacists in Coon Rapids, Minnesota


60 Pharmacists found in Coon Rapids
male pharmacist

Mohamed Aboubadria


Pharmacist
8600 Springbrook Dr Nw, Coon Rapids, MN 55433
763-785-0720    

female pharmacist

Nicole Marie Hendricks, PHARMD, RPH


Pharmacist
3470 River Rapids Dr Nw, Coon Rapids, MN 55448
763-427-1156     763-427-1562

female pharmacist

Sandra Jean Georgeson, RPH


Pharmacist
13020 Riverdale Dr Nw, Coon Rapids, MN 55448
763-421-5717     763-421-6418



female pharmacist

Sara Asmus


Pharmacist
8600 Springbrook Dr Nw, Coon Rapids, MN 55433
763-785-0720    

female pharmacist

Mrs. Sarah Rose Johnson, RPH


Pharmacist
4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433
763-236-7123    

male pharmacist

Dr. Sean Matthew Pfundstein, PHARMD


Pharmacist
3470 River Rapids Dr Nw, Coon Rapids, MN 55448
763-427-1156    

female pharmacist

Dr. Spring Lorraine Romer, PHARM D


Pharmacist
12547 Riverdale Blvd Nw, Coon Rapids, MN 55448
763-712-7762     763-712-7783

male pharmacist

Dr. Steven J Bruin, PHARMD


Pharmacist
12547 Riverdale Blvd Nw, Coon Rapids, MN 55448
763-712-7762     763-712-7783

female pharmacist

Mrs. Suzan Nusseibeh, PHARMACIST


Pharmacist
3470 River Rapids Dr Nw, Coon Rapids, MN 55448
763-427-1156    

male pharmacist

Mr. Syed S Ahmed, PHARM-D


Pharmacist
2017 Coon Rapids Blvd Nw, Coon Rapids, MN 55433
763-757-5615     763-862-3988

male pharmacist

Dr. Troy Burke, PHARMD


Pharmacist
10686 University Ave Nw, Coon Rapids, MN 55448
763-755-1259    

male pharmacist

Xiong Vang


Pharmacist
3300 124th Ave Nw, Coon Rapids, MN 55433
763-354-1626    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.